# OD-PHOENIX in Talus Osteochondral Lesion

> **NCT02736318** · PHASE1,PHASE2 · TERMINATED · sponsor: **TBF Genie Tissulaire** · enrollment: 12 (actual)

## Conditions studied

- Talus Osteochondral Defect

## Interventions

- **BIOLOGICAL:** OD-PHOENIX

## Key facts

- **NCT ID:** NCT02736318
- **Lead sponsor:** TBF Genie Tissulaire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-01-27
- **Primary completion:** 2021-09-07
- **Final completion:** 2021-09-07
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Low accrual rate
- **Last updated:** 2022-01-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02736318

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02736318, "OD-PHOENIX in Talus Osteochondral Lesion". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02736318. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*